Cesca Therapeutics Inc (NASDAQ:KOOL)

0.459
Delayed Data
As of Jul 13
 -0.0285 / -5.85%
Today’s Change
0.37
Today|||52-Week Range
6.44
-84.70%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$12.9M

Company Description

Cesca Therapeutics, Inc. engages in the research, development, and commercialization of autologous cell-based therapeutics for use in regenerative medicine. It operates through the Clinical Development Division and Device Division business segments. The Clinical Development Division segment involves in developing autologous stem cell-based therapeutics that address significant unmet medical needs for applications within the vascular, cardiology, and orthopedic markets. The Device Division segment includes development and commercialization of automated technologies for cell-based therapeutics and bio-processing. The company was founded by Philip H. Coelho in 1986 and is headquartered in Rancho Cordova, CA.

Contact Information

Cesca Therapeutics, Inc.
2711 Citrus Road
Rancho Cordova California 95742
P:(916) 858-5100
Investor Relations:
(916) 858-5191

Employees

Shareholders

Individual stakeholders61.08%
Mutual fund holders1.24%
Other institutional1.17%

Top Executives

Xiao Chun XuChairman, President & Chief Executive Officer
Vivian H. LiuChief Operating Officer, Secretary & Director
Jeffery CaublePrincipal Financial & Accounting Officer
Philip H. CoelhoChief Technology Officer
Dalip SethiSenior Director-Research & Development